PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
1-ethylpiperazine 226-166-6 5308-25-8 - - - - 1 - - - - Details
Sodium octane-1-sulphonate monohydrate 226-195-4 5324-84-5 - - - - 1 - - - - Details
Sulphamidic acid 226-218-8 5329-14-6 - - 3 - - 1 - - - Details
3-methoxypropylamine 226-241-3 5332-73-0 - - 2 - - - - - - Details
2-octyldodecan-1-ol 226-242-9 5333-42-6 - 1 3 - - - - - - Details
1,2,3,6-tetrahydro-3-methylphthalic anhydride 226-247-6 5333-84-6 - - 1 - 1 - - - - Details
Chloromethyl benzoate 226-254-4 5335-05-7 - - - - 1 - - - - Details
Pentane-1,2-diol 226-285-3 5343-92-0 - - 2 - 1 - - - - Details
1,1,1,5,5,5-hexamethyl-3-[(trimethylsilyl)oxy)-3-vinyltrisiloxane 226-342-2 5356-84-3 - - - - 1 - - - - Details
Piperidin-4-ol 226-373-1 5382-16-1 - - - - 1 - - - - Details
4,4'-methylenedi-2,6-xylenol 226-378-9 5384-21-4 - - 2 2 2 - - - - Details
Citral 226-394-6 5392-40-5 1 - 4 - - 1 - - - Details
Ammonium mercaptoacetate 226-540-9 5421-46-5 - - 2 - - - - - - Details
N-2-hydroxyethyllactamide 226-546-1 5422-34-4 - - - - 1 - - - - Details
Guanidinium phosphate (1:1) 226-551-9 5423-22-3 - - 1 - 1 - - - - Details
Bisguanidinium phosphate 226-552-4 5423-23-4 - - - - 1 - - - - Details
2-ethylhexyl benzoate 226-641-8 5444-75-7 - - 3 - 1 - - - - Details
2-butoxyethyl benzoate 226-685-8 5451-76-3 - - - - 1 - - - - Details
3-(p-methoxyphenyl)-2-methylpropionaldehyde 226-749-5 5462-06-6 - - 1 - 1 - - - - Details
4-(4-hydroxyphenyl)butan-2-one 226-806-4 5471-51-2 - - 1 - 1 - - - - Details
2-isopropyl-9H-thioxanthen-9-one 226-827-9 5495-84-1 - - 1 - 1 - - - - Details
2-bromo-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide 226-844-1 5504-92-7 - - - - 1 - - - - Details
2,9-dimethylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 226-866-1 5521-31-3 1 1 1 - - - - - - Details
2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide] 226-939-8 5567-15-7 - 1 2 - - - - - - Details
Dichlorocyclohexylmethylsilane 226-956-0 5578-42-7 - - 1 - 1 - - - - Details
3,3'-[(2-chloro-5-methyl-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(3-chloro-o-tolyl)benzamide] 226-970-7 5580-57-4 - - 1 - - - - - - Details
3,3'-[(2,5-dichloro-p-phenylene)bis[imino(1-acetyl-2-oxoethylene)azo]]bis[4-chloro-N-(5-chloro-o-tolyl)benzamide] 226-971-2 5580-58-5 - - 2 - - - - - - Details
3-3-diphenylpropylamine 226-984-3 5586-73-2 - - - - 1 - - - - Details
3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one] 226-999-5 5590-18-1 - - 1 - - - - - - Details
Titanium tetrabutanolate 227-006-8 5593-70-4 - - 1 - - - - - - Details
4,4'-isopropylidenedi-2,6-xylol 227-033-5 5613-46-7 1 - - - 1 - - - - Details
N,N'-methylenebismorpholine 227-062-3 5625-90-1 - - - - - 1 - - - Details
Ethylenediamine-N,N'-di(acetic acid) 227-105-6 5657-17-0 - - 1 - 1 - - - - Details
Dodecane-1,12-diol 227-133-9 5675-51-4 - - 1 - 1 - - - - Details
Magnesium acrylate 227-177-9 5698-98-6 - - - - 1 - - - - Details
N-(tri(hydroxymethyl)methyl)glycine 227-193-6 5704-04-1 - - 1 - 1 - - - - Details
1,1,3,3-tetramethylbutyl hydroperoxide 227-369-2 5809-08-5 - - 2 - 1 - - - - Details
O,O-bis(2-ethylhexyl) hydrogen dithiophosphate 227-376-0 5810-88-8 - - - - 1 - - - - Details
2-[(tetrahydrofurfuryl)oxy]ethanol 227-407-8 5831-59-4 - - - - 1 - - - - Details
N,N-dibutyloleamide 227-410-4 5831-80-1 - - - - 1 - - - - Details
Coumatetralyl 227-424-0 5836-29-3 - - - - - 1 - - - Details
o-(p-isocyanatobenzyl)phenyl isocyanate 227-534-9 5873-54-1 - 1 1 - 3 - - - - Details
Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate 227-561-6 5888-33-5 - - 1 - 1 1 - - - Details
N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide) 227-563-7 5888-87-9 - - 1 - 1 - - - - Details
Trichloro(hexadecyl)silane 227-575-2 5894-60-0 - - 1 - 1 - - - - Details
Dineodymium tricarbonate 227-579-4 5895-46-5 - - 2 - 1 - - - - Details
Terbuthylazine 227-637-9 5915-41-3 - - - - - 1 - - - Details
2,3-dihydroxypropyl methacrylate 227-642-6 5919-74-4 - - 1 - 1 - - - - Details
Tetrapotassium ethylenediaminetetraacetate 227-743-5 5964-35-2 - - - - 1 - - - - Details
(R)-p-mentha-1,8-diene 227-813-5 5989-27-5 - - 2 - - 1 - - - Details

Export search results to: